Intravitreal Injections

"Intravitreal Injections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The administration of substances into the VITREOUS BODY of the eye with a hypodermic syringe.

Descriptor ID	D058449
MeSH Number(s)	E02.319.267.530.475.500
Concept/Terms	Intravitreal Injections Intravitreal Injections Injection, Intravitreal Injections, Intravitreal Intravitreal Injection

Below are MeSH descriptors whose meaning is more general than "Intravitreal Injections".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Administration Routes [E02.319.267]
Injections [E02.319.267.530]
Injections, Intraocular [E02.319.267.530.475]
Intravitreal Injections [E02.319.267.530.475.500]

Below are MeSH descriptors whose meaning is related to "Intravitreal Injections".

Below are MeSH descriptors whose meaning is more specific than "Intravitreal Injections".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Intravitreal Injections" by people in this website by year, and whether "Intravitreal Injections" was a major or minor topic of these publications.

Bar chart showing 42 publications over 15 distinct years, with a maximum of 8 publications in 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2010	0	1	1
2011	0	1	1
2012	3	0	3
2013	0	1	1
2014	2	1	3
2015	0	4	4
2016	0	8	8
2017	0	3	3
2019	0	1	1
2020	1	0	1
2021	0	4	4
2022	0	4	4
2023	1	3	4
2024	0	3	3
2025	0	1	1

Below are the most recent publications written about "Intravitreal Injections" by people in Profiles.

Khanani AM, Danzig CJ, Heier JS, Jaffe GJ, Kaiser PK, Lally DR, Patel SS, Vajzovic L, Weng CY, Patel H, Clark J, Desai D, Luo D, Henry E, Holz FG. Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration: Two-Year Efficacy and Safety Results from the GATHER2 Phase 3 Trial. Ophthalmology. 2026 04; 133(4):451-465.

View in: PubMed
Yip JY, Geckeler KC, Barton KM, Roh S, Ramsey DJ. Impact of a Patient Portal-Based Telehealth Outreach Program on Recall of Patients with Diabetic Retinopathy. Telemed J E Health. 2025 Apr; 31(4):459-467.

View in: PubMed
Danzig CJ, Khanani AM, Kaiser PK, Chang MA, Kovach JL, Lally DR, Rachitskaya A, Sheth VS, Vajzovic L, Clark J, Tang J, Zhu L, Desai D, Chakravarthy U. Vision Loss Reduction with Avacincaptad Pegol for Geographic Atrophy: A 12-Month Post Hoc Analysis of the GATHER1 and GATHER2 Trials. Ophthalmol Retina. 2024 11; 8(11):1052-1060.

View in: PubMed
Lam A, Gulati S, Foster BS, Lally DR. CENTRAL RETINAL VEIN OCCLUSION ASSOCIATED WITH USE OF AMYL NITRITE "POPPERS". Retin Cases Brief Rep. 2024 Jan 01; 18(1):138-140.

View in: PubMed
Archambault SD, Nichols MM, McCullum JC, Zhang Y, Steinberger EE, Ramsey DJ. Patient adherence to therapy after switch to aflibercept from bevacizumab or ranibizumab for treatment-refractory neovascular age-related macular degeneration. Indian J Ophthalmol. 2024 01 01; 72(Suppl 1):S101-S105.

View in: PubMed
Khanani AM, Patel SS, Staurenghi G, Tadayoni R, Danzig CJ, Eichenbaum DA, Hsu J, Wykoff CC, Heier JS, Lally DR, Mon?s J, Nielsen JS, Sheth VS, Kaiser PK, Clark J, Zhu L, Patel H, Tang J, Desai D, Jaffe GJ. Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial. Lancet. 2023 Oct 21; 402(10411):1449-1458.

View in: PubMed
Akkan Aydogmus FS, Onwuka O, Saddemi J, Lasalle CC, Ramsey DJ. Second eyes to develop neovascular age-related macular degeneration have fewer symptoms and better one-year visual outcomes. BMC Ophthalmol. 2023 Jul 07; 23(1):303.

View in: PubMed
Patel SS, Lally DR, Hsu J, Wykoff CC, Eichenbaum D, Heier JS, Jaffe GJ, Westby K, Desai D, Zhu L, Khanani AM. Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial. Eye (Lond). 2023 12; 37(17):3551-3557.

View in: PubMed
Samuelson AG, Nahar A, Patel SN, Mahmoudzadeh R, Salabati M, Yu-Chuan Kang E, Hinkle JW, Soares RR, Kuriyan AE, Garg SJ. CLINICAL OUTCOMES OF PATIENTS WITH ENDOPHTHALMITIS AFTER DEXAMETHASONE INTRAVITREAL IMPLANT. Retina. 2022 10 01; 42(10):1915-1920.

View in: PubMed
Patel SN, Mokhashi N, Peck TJ, Cai LZ, Salabati M, Soares RR, Hinkle J, Chaudhary V, Kuriyan AE, Cohen MN, Hsu J, Garg SJ. Seasonal and Environmental Variations in Endophthalmitis after Intravitreal Anti-vascular Endothelial Growth Factor Injection: A Six-year Review. Curr Eye Res. 2022 09; 47(9):1288-1293.

View in: PubMed

People

Explore

Similar Concepts

Top Journals